Last Updated: May 10, 2026

Suppliers and packagers for generic pharmaceutical drug: IBUPROFEN SODIUM


✉ Email this page to a colleague

« Back to Dashboard


IBUPROFEN SODIUM

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Haleon Us Holdings ADVIL ibuprofen sodium TABLET;ORAL 201803 NDA Haleon US Holdings LLC 0573-0133-01 3000 PACKET in 1 CASE (0573-0133-01) / 2 TABLET, COATED in 1 PACKET 2013-07-08
Haleon Us Holdings ADVIL ibuprofen sodium TABLET;ORAL 201803 NDA Haleon US Holdings LLC 0573-0133-02 50 PACKET in 1 TRAY (0573-0133-02) / 2 TABLET, COATED in 1 PACKET 2013-07-08
Haleon Us Holdings ADVIL ibuprofen sodium TABLET;ORAL 201803 NDA Haleon US Holdings LLC 0573-0133-04 2 PACKET in 1 BLISTER PACK (0573-0133-04) / 2 TABLET, COATED in 1 PACKET 2013-07-08
Haleon Us Holdings ADVIL ibuprofen sodium TABLET;ORAL 201803 NDA Haleon US Holdings LLC 0573-0133-05 2 PACKET in 1 CARTON (0573-0133-05) / 2 TABLET, COATED in 1 PACKET 2013-07-08
Haleon Us Holdings ADVIL ibuprofen sodium TABLET;ORAL 201803 NDA Haleon US Holdings LLC 0573-0133-20 1 BOTTLE in 1 CARTON (0573-0133-20) / 20 TABLET, COATED in 1 BOTTLE 2013-07-08
Haleon Us Holdings ADVIL ibuprofen sodium TABLET;ORAL 201803 NDA Haleon US Holdings LLC 0573-0133-40 1 BOTTLE in 1 CARTON (0573-0133-40) / 40 TABLET, COATED in 1 BOTTLE 2013-07-08
Haleon Us Holdings ADVIL ibuprofen sodium TABLET;ORAL 201803 NDA Haleon US Holdings LLC 0573-0133-41 1 BOTTLE in 1 CARTON (0573-0133-41) / 40 TABLET, COATED in 1 BOTTLE 2013-07-08
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for generic pharmaceutical drug: IBUPROFEN SODIUM

Last updated: April 22, 2026

Who Supplies Ibuprofen Sodium for Pharma Use?

Ibuprofen sodium (an ibuprofen salt, typically formulated as an oral solid, topical gel, or liquid suspension ingredient) is sourced from multiple global chemical and specialty pharmaceutical supply channels: API/salt makers, salt intermediates manufacturers, and finished-dose formulation supply chains. Market supply is dominated by large chemical firms that sell ibuprofen sodium as a registered or spec’d salt, alongside regional excipient/active-salt suppliers that support contract manufacturing and formulation.

What types of suppliers deliver ibuprofen sodium?

Supply channel What the supplier provides Common customer end-use Typical documentation
API/salt manufacturers Ibuprofen sodium as an API/salt substance (often with CoA, spec sheets) Direct use for finished-dose manufacturing CoA; compendial or internal specs; impurity profile; manufacturing route description under NDA
Specialty chemical firms Ibuprofen sodium as a chemical intermediate/salt grade Formulation development; pilot scale MSDS/SDS; stability data (limited); impurity data (varies by supplier)
Contract development and manufacturing (CDMO) supply ecosystem Ibuprofen sodium sourced and controlled by the CDMO network Commercial manufacturing with supply assurance Vendor qualification package; change control; batch records under GMP
Regional distributors Lot-by-lot distribution from underlying manufacturers Procurement coverage Distributor CoA; traceability; sometimes reduced right-to-audit

Which supplier categories matter for procurement and qualification?

For pharmaceutical use, procurement typically hinges on whether the supplier can provide:

  • GMP supply with batch traceability (not just chemical-grade material)
  • Compliance documentation (CoA for each batch, impurity profile, and controlled specifications)
  • Regulatory readiness (DMF/CEP support where applicable, or GMP/quality dossiers via customer NDA)

Ibuprofen sodium is commonly sourced through the same supplier ecosystem used for ibuprofen (free acid) and ibuprofen derivatives, but qualification focuses on salt identity, residual impurities, and water/solvate behavior (where relevant to spec).


Which companies commonly supply ibuprofen sodium?

The supplier universe for ibuprofen sodium spans global API and specialty chemical firms, often with multiple grade types. Without a specific regulatory geography (US/EU/India/China) and intended dosage form, the most business-relevant approach is to segment by supplier capability: GMP API/salt versus chemical grade versus CDMO-controlled sourcing.

GMP-oriented API/salt suppliers (pharma supply chain)

These suppliers are typically active in ibuprofen and ibuprofen salts, with the ability to supply pharmaceutical-grade material and support regulatory documentation under qualification.

Examples of supplier types (global):

  • Ibuprofen and ibuprofen salt producers in China and India with established API sales arms for NSAIDs and analgesics
  • Multi-product API manufacturers in Europe that sell ibuprofen-related substances and can support GMP supply

Specialty chemical manufacturers (often sold as salt-grade)

Specialty chemical suppliers often offer ibuprofen sodium as a defined chemical salt. Some provide documentation suitable for development and pilot batches, but may require additional qualification for full commercial use.

Examples of supplier types (global):

  • Chemical companies with catalog ibuprofen sodium listings and specification sheets
  • Salt/derivative specialists that sell ibuprofen sodium under internal grades

Distributors (traceability-focused)

Distributors commonly route product from underlying manufacturers. This can speed procurement, but qualification still depends on the underlying manufacturer’s quality system and release specs.


How to evaluate and shortlist ibuprofen sodium suppliers (qualification checklist)

What specifications determine supplier fit?

Ibuprofen sodium sourcing quality is usually judged against:

  • Identity (salt form confirmation, polymorph/solvate behavior if relevant)
  • Assay and content uniformity (active salt content)
  • Related substances (ibuprofen-related and synthesis-related impurities)
  • Residual solvents and metals (as applicable to the manufacturing route)
  • Water content / hygroscopicity (salt stability and handling impact)
  • Particle size and bulk density (for solids manufacturing flow and compressibility)

What documentation should be in the qualification package?

For pharma use, procurement typically requires:

  • CoA per lot with test methods and results
  • Spec sheet with acceptance criteria
  • Manufacturing site GMP status (certificate and audit history if available)
  • Change control commitments (source, process, or spec changes)
  • Impurity profile including any controlled threshold strategy
  • Stability data (accelerated/real-time relevant to dosage form if provided)

What matters most for ibuprofen sodium vs ibuprofen free acid?

Even when the active is “ibuprofen,” the salt form changes:

  • Stability and handling (hygroscopic behavior can differ)
  • Solubility profile (affects formulation development and dissolution specs)
  • Impurity carryover (route-specific byproducts)
  • Regulatory documentation (salt substance vs drug substance nomenclature and control strategy)

Supplier selection by business use case

If you manufacture tablets/capsules

Prioritize GMP API/salt suppliers with consistent lot-to-lot impurity and solid-state performance. Qualification usually requires a supplier with:

  • Defined particle specs and moisture control
  • A repeatable synthesis route
  • Documented residual solvent and metal limits

If you develop topical gels or solutions

Topical and liquid dosage forms are sensitive to salt solubility and stability. Procurement prioritizes suppliers that can provide:

  • Salt grade consistency and water control
  • Impurity profiles that do not drive discoloration or irritancy risk
  • Handling guidance for hygroscopic materials

If you outsource via a CDMO

The CDMO’s vendor network matters more than catalog procurement. The best supplier outcome comes from:

  • CDMO-controlled sourcing and vendor qualification
  • Ability to switch suppliers under change control without reformulation

Key Takeaways

  • Ibuprofen sodium is typically supplied through the API/salt manufacturing ecosystem plus specialty chemical suppliers and distributors that route underlying GMP producers.
  • Supplier qualification is driven by salt identity, impurity profile, water/hygroscopicity control, and GMP documentation, not just assay.
  • For commercial-grade supply, shortlist GMP-oriented API/salt manufacturers that can provide per-lot CoA, spec sheets, impurity details, and controlled change management.

FAQs

1) Is ibuprofen sodium usually supplied as an API or as a chemical salt grade?

It is supplied both ways. Pharma-grade supply is typically handled as an API/salt substance with GMP documentation; development and pilot supplies may be offered as salt-grade chemical material.

2) What are the top quality risks when qualifying ibuprofen sodium?

Water/hygroscopicity behavior, salt identity consistency, and impurity profile variability across lots and manufacturing routes.

3) Do suppliers of ibuprofen also supply ibuprofen sodium?

Many ibuprofen API suppliers also offer ibuprofen sodium or ibuprofen salt derivatives, but qualification is still specific to the salt form and its impurity/control strategy.

4) Can I source ibuprofen sodium through a distributor?

Yes, but distributor supply depends on underlying manufacturer compliance. Qualification still targets the manufacturer CoA/spec, traceability, and documentation.

5) What documentation is usually mandatory for GMP procurement?

Per-lot CoA, supplier spec sheet, manufacturing site GMP status, and impurity/water controls. For commercial filings, dossier support (DMF/CEP equivalent) may be required depending on region.


References

[1] European Pharmacopoeia. Ibuprofen Sodium. European Pharmacopoeia monographs (latest edition).
[2] United States Pharmacopeia. Ibuprofen Sodium. USP–NF monograph (latest edition).
[3] European Medicines Agency. Guideline on setting specification limits for residual solvents / related Q&A resources (applicable quality documentation standards).
[4] ICH. Q3A(R2) Impurities in New Drug Substances. ICH Guidance.
[5] ICH. Q3C(R8) Impurities: Guideline for Residual Solvents and Impurity Control (as applicable to substance control).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing